CCL20 and infection: Interestingly, although this vaccination strategy, i.e., IM vaccination with the MIP-3α/relMtb, fusion construct, yielded improved microbiological outcomes when combined with INH compared to the non-fused relMtb vaccine, no Th1 response was observed in the lungs, the primary site of the infection.